Related Experiment Video
Updated: Jan 15, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Multidimensional Strategies in Oncology: From Macrocyclic Kinase Inhibitors to Physicochemical and Transcriptomic
Anna C Renner1, Robert B Kargbo2
1North Dakota State University, Fargo, North Dakota 58108-6050, United States.
Abstract:
Three recent inventions highlight complementary advances in oncology: macrocyclic multitarget ALK inhibitors for resistant NSCLC, impedance-based cfDNA staging as a label-free diagnostic, and transcriptome-driven prediction of KRAS inhibitor response. Together, they illustrate an emerging paradigm in precision oncology that integrates molecular design, biophysical classification, and computational phenotyping to refine therapeutic selection and improve clinical outcomes.
Insights
Precision oncology advances include new ALK inhibitors for non-small cell lung cancer (NSCLC), label-free cfDNA staging, and transcriptome-based KRAS inhibitor response prediction. These innovations refine cancer treatment selection for better outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biophysics
Background:
- Precision oncology aims to tailor cancer treatments to individual patients.
- Advances in molecular diagnostics and targeted therapies are crucial for improving patient outcomes.
- Current challenges include drug resistance and accurate patient stratification.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers

